drugset / Trial / NCT04040127
Residual Dental Pulp Tissue and Cord Blood Stem Cells
RandomizedParallel-groupDouble-blindTreatment
Summary
The experiments outlined in this proposal are designed to test the hypothesis that the in vivo injection of cord blood stem cells (InvitRx®) into the root canal system will facilitate teeth initially diagnosed with irreversible pulpitis, to form normal healthy pulpal tissue.
Timeline
- Start
- 2019-09-01
- Primary completion
- 2020-01-15
- Completion
- 2020-02-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cord blood stem cells | Cell therapy | 1 ml | Other |
| Subject | Cord blood stem cells | Cell therapy | 3e+07 cells | Other |